Ryo Ijima
Japanese Red Cross Nagoya Daiichi Hospital(JP)Nagoya University(JP)
Publications by Year
Research Areas
Retinal Diseases and Treatments, Retinal Development and Disorders, Glaucoma and retinal disorders, Ocular Diseases and Behçet’s Syndrome, melanin and skin pigmentation
Most-Cited Works
- → Plasma-activated medium suppresses choroidal neovascularization in mice: a new therapeutic concept for age-related macular degeneration(2015)54 cited
- → Interleukin-18 Induces Retinal Pigment Epithelium Degeneration in Mice(2014)49 cited
- → IL-18 is not therapeutic for neovascular age-related macular degeneration(2014)42 cited
- → Human IgG1 antibodies suppress angiogenesis in a target-independent manner(2016)37 cited
- → Histamine H4 receptor as a new therapeutic target for choroidal neovascularization in age‐related macular degeneration(2014)22 cited
- → Suppression of Laser-Induced Choroidal Neovascularization by the Oral Medicine Targeting Histamine Receptor H4 in Mice(2015)7 cited
- Histamine Receptor H4 as a New Therapeutic Target for Choroidal Neovascularization in Age-related Macular Degeneration(2014)
- Anti-histamine receptor h4 treatment reduced choroidal neovascularization independent of vascular endothelial growth factor(2014)
- Interleukin-18 induced retinal pigment eithelium cell death, but did not suppress choroidal neovascularization in mice(2013)
- Anti-histamine receptor 4 therapy inhibits choroidal neovascularization in mice(2013)